Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050154
Status:
COMPLETED
Last Update Posted:
2010-04-27
First Post:
2002-11-22
Brief Title:
Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome MDS
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC